1. Home
  2. OVID

OVID

Ovid Therapeutics Inc.

Logo Ovid Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:04pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Founded: 2014 Country:
N/A
Employees: 40 City: NEW YORK
Market Cap: 222.7M IPO Year: 2017
Target Price: $8.00 AVG Volume (30 days): 210.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.74 EPS Growth: N/A
52 Week Low/High: $2.57 - $4.14 Next Earning Date: 01-01-0001
Revenue: $391,695 Revenue Growth: -73.93%
Revenue Growth (this year): -36.67% Revenue Growth (next year): 19432.46%

Share on Social Networks: